LPL Financial
LSTA icon

LPL Financial’s Lisata Therapeutics LSTA Stock Holding History

LPL Financial’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-85
Closed -$10K – 2828
2016
Q1 		$10K Sell
85
-30
-26% -$2.95K ﹤0.01% 3076
2015
Q4 		$18K Buy
+115
New +$21.1K ﹤0.01% 3106

Other funds holding LSTA

GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
OC
Oppenheimer & Co New York $8.21B AUM 28.81% 1-Year Est. Return

LPL Financial's LSTA Position: Q2 2016 in Review

LPL Financial sold out of Lisata Therapeutics (LSTA) in Q2 2016, closing a stake of 85 shares — an estimated $10K sold.

LPL Financial first reported a position in LSTA in Q4 2015 and held it in 2 quarters. The position peaked at $18K in Q4 2015. 43 funds tracked by Wall St. Rank hold LSTA as of Q2 2016.

  • LPL Financial reported no remaining Lisata Therapeutics position as of Q2 2016 after selling out during the quarter.
  • LPL Financial sold 85 Lisata Therapeutics shares in Q2 2016, an estimated $10K.
  • LPL Financial first reported a position in Lisata Therapeutics in Q4 2015 and held it in 2 quarters.
  • LPL Financial's Lisata Therapeutics position peaked at $18K in Q4 2015.
  • 43 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q2 2016.

Based on LPL Financial's 13F filing for Q2 2016, filed 15 Aug 2016.